TERN logo

Terns Pharmaceuticals, Inc. (TERN)

Profile

Full Name

Terns Pharmaceuticals, Inc.

Ticker

NASDAQ: TERN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 5, 2021

Indexes

Not included

Website

https://www.ternspharma.com

Employees

59

Key Details

Price

$40.23(37.02%)

Market Cap

$3.62B(Mid cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-$1.12(11.72% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $40.23
    TERN price is $40.23

    30-Day Relative Volume

    2.69
    TERN 30-day relative volume is 2.69

    Price Performance

    Price Most Recent Change

    +37.02%
    TERN price was up +37.02% on Dec 8, 2025

    Price YTD Change

    +626.17%
    TERN price is up +626.17% since January 1st

    Price 1-Year Change

    +511.4%
    TERN price is up +511.4% year-on-year

    Price 3-Year Change

    +627.49%
    TERN price is up +627.49% over the past 3 years

    Price Range

    Price All-Time High

    $45.00
    TERN price is currently -10.60% below its historical high of $45.00

    Price 3-Year Low

    $1.86
    TERN price is currently +2057.10% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $3.62B
    TERN market cap is $3.62 billion

    Market Cap 3-Year Change

    +1642.23%
    TERN market cap is up +1642.23% over the past 3 years

    Market Cap All-Time High

    $3.62B
    TERN market cap is currently at an all-time high

    Market Cap Sector Percentile

    85.09%
    TERN market cap is higher than 85.09% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +6.05%
    TERN shares outstanding is up +6.05% year-on-year

    Shares Outstanding 3-Year Change

    +139.49%
    TERN shares outstanding is up +139.49% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.16
    TERN beta is 1.16

    200-day SMA

    $7.46
    TERN price is currently +438.93% above its 200-day simple moving average

    50-day SMA

    $16.36
    TERN price is currently +145.95% above its 50-day simple moving average

    14-Day RSI

    84.94
    TERN 14-day relative strength index is 84.94

    Volume

    2.69
    TERN 30-day relative volume is 2.69

    ATR

    $2.81
    TERN average true range is $2.81

    10-day Historical Volatility

    195.15%
    TERN 10-day historical volatility is 195.15%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    TERN annual revenue is $0.00

    Revenue Analysts Estimate

    -
    TERN annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    0%
    TERN annual revenue has remained unchanged year-on-year

    Revenue Sector Percentile

    28.27%
    TERN annual revenue is higher than 28.27% of companies in Healthcare sector

    EPS

    EPS

    -$1.12
    TERN annual earnings per share is -$1.12

    EPS Analysts Estimate

    -$1.10
    TERN annual earnings per share is currently -1.38% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +11.72%
    TERN annual earnings per share is up +11.72% year-on-year

    EPS Sector Percentile

    54.12%
    TERN annual earnings per share is higher than 54.12% of companies in Healthcare sector

    Profit

    Gross Profit

    -$896.00K
    TERN annual gross profit is -$896.00 thousand

    Gross Margin

    -
    TERN annual gross profit margin value is unknown

    Operating Profit

    -$101.87M
    TERN annual operating income is -$101.87 million

    Operating Margin

    -
    TERN annual operating profit margin value is unknown

    Net Income

    -$88.85M
    TERN annual net profit is -$88.85 million

    Net Margin

    -
    TERN annual net profit margin value is unknown

    Expenses

    Total Expenses

    $101.87M
    TERN annual total expenses is $101.87 million

    Operating Expenses

    $101.87M
    TERN annual total operating expenses is $101.87 million

    Cost Of Goods Sold

    $896.00K
    TERN annual cost of goods sold is $896.00 thousand

    Selling, General & Administrative Expenses

    $31.76M
    TERN annual SG&A is $31.76 million

    Depreciation & Amortization

    $896.00K
    TERN annual D&A is $896.00 thousand

    Interest Expense

    $0.00
    TERN annual interest expense is $0.00

    Income Tax

    $260.00K
    TERN annual income tax is $260.00 thousand

    EBIT & EBITDA

    EBIT

    -$101.87M
    TERN annual earnings before interest & taxes is -$101.87 million

    EBITDA

    -$100.97M
    TERN annual EBITDA is -$100.97 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $363.93M
    TERN annual total assets is $363.93 million

    Non Current Assets

    $1.82M
    TERN annual long term assets is $1.82 million

    Current Assets

    $362.11M
    TERN annual total current assets is $362.11 million

    Cash and Cash Equivalents

    $161.44M
    TERN annual cash & cash equivalents is $161.44 million

    Accounts Receivable

    -
    TERN annual accounts receivable value is unknown

    Inventory

    $0.00
    TERN annual inventory is $0.00

    Liabilities

    Total Liabilities

    $18.06M
    TERN annual total liabilities is $18.06 million

    Long Term Liabilities

    $2.41M
    TERN annual total long term liabilities is $2.41 million

    Current Liabilities

    $15.65M
    TERN annual current liabilities is $15.65 million

    Accounts Payable

    $2.15M
    TERN annual accounts payable is $2.15 million

    Debt

    Total Debt

    $1.35M
    TERN annual total debt is $1.35 million

    Total Debt 1-Year Change

    +123.38%
    TERN annual total debt is up +123.38% year-on-year

    Long Term Debt

    $919.00K
    TERN annual long term debt is $919.00 thousand

    Short Term Debt

    $428.00K
    TERN annual short term debt is $428.00 thousand

    Equity & Capital

    Shareholders Equity

    $345.87M
    TERN annual stockholders equity is $345.87 million

    Book Value

    $345.87M
    TERN annual book value is $345.87 million

    Retained Earnings

    -$421.48M
    TERN annual retained earnings is -$421.48 million

    Working Capital

    $346.46M
    TERN annual working capital is $346.46 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$70.02M
    TERN annual cash from operations is -$70.02 million

    Cash From Operations 1-Year Change

    -3.9%
    TERN annual cash from operations is down -3.9% year-on-year

    Cash From Investing

    -$12.41M
    TERN annual cash from investing is -$12.41 million

    Cash From Investing 1-Year Change

    +67.33%
    TERN annual cash from investing is up +67.33% year-on-year

    Cash From Financing

    $164.00M
    TERN annual cash from financing is $164.00 million

    Cash From Financing 1-Year Change

    +290.92%
    TERN annual cash from financing is up +290.92% year-on-year

    CAPEX

    CAPEX

    $42.00K
    TERN annual capital expenditures is $42.00 thousand

    CAPEX 1-Year Change

    -19.23%
    TERN annual capital expenditures is down -19.23% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$70.06M
    TERN annual free cash flow is -$70.06 million

    Free Cash Flow 1-Year Change

    -3.88%
    TERN annual free cash flow is down -3.88% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    TERN annual gross profit margin value is unknown

    Operating Margin

    -
    TERN annual operating profit margin value is unknown

    Net Margin

    -
    TERN annual net profit margin value is unknown

    ROA & ROE

    ROA

    -28.10%
    TERN annual return on assets is -28.10%

    ROE

    -29.56%
    TERN annual return on equity is -29.56%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    TERN price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    TERN price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    12.76
    TERN price to book ratio is 12.76

    PB Ratio Sector Percentile

    90.5%
    TERN price to book ratio is higher than 90.5% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    TERN price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    TERN price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $3.33B
    TERN enterprise value is $3.33 billion

    Enterprise Value Sector Percentile

    83.63%
    TERN enterprise value is higher than 83.63% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -30.86
    TERN EV/EBITDA is -30.86

    EV/EBITDA Sector Percentile

    4.65%
    TERN EV/EBITDA is higher than 4.65% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    23.14
    TERN annual current ratio is 23.14

    Quick Ratio

    23.14
    TERN annual quick ratio is 23.14

    Leverage

    Debt To Equity

    0.00
    TERN annual debt to equity ratio is 0.00

    Interest Coverage Ratio

    -
    TERN annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    TERN piotroski f-score value is unknown

    Altman Z-Score

    119.00
    TERN altman z-score is 119.00

    Analyst ratings

    Recent major analysts updates

    Nov 26, 25 Citizens
    Market Outperform
    Nov 25, 25 Barclays
    Overweight
    Nov 19, 25 Truist Securities
    Buy
    Nov 18, 25 BMO Capital
    Outperform
    Nov 13, 25 Mizuho
    Outperform
    Nov 11, 25 Barclays
    Overweight
    Nov 4, 25 Truist Securities
    Buy
    Nov 4, 25 Mizuho
    Outperform
    Nov 4, 25 HC Wainwright & Co.
    Buy
    Nov 4, 25 Barclays
    Overweight

    Institutional Ownership

    Screeners with TERN included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    • What is the ticker symbol for Terns Pharmaceuticals, Inc.?
    • Does Terns Pharmaceuticals, Inc. pay dividends?
    • What sector is Terns Pharmaceuticals, Inc. in?
    • What industry is Terns Pharmaceuticals, Inc. in?
    • What country is Terns Pharmaceuticals, Inc. based in?
    • When did Terns Pharmaceuticals, Inc. go public?
    • Is Terns Pharmaceuticals, Inc. in the S&P 500?
    • Is Terns Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Terns Pharmaceuticals, Inc. in the Dow Jones?
    • When was Terns Pharmaceuticals, Inc.'s last earnings report?
    • When does Terns Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Terns Pharmaceuticals, Inc.?

    The ticker symbol for Terns Pharmaceuticals, Inc. is NASDAQ:TERN

    Does Terns Pharmaceuticals, Inc. pay dividends?

    No, Terns Pharmaceuticals, Inc. does not pay dividends

    What sector is Terns Pharmaceuticals, Inc. in?

    Terns Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Terns Pharmaceuticals, Inc. in?

    Terns Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is Terns Pharmaceuticals, Inc. based in?

    Terns Pharmaceuticals, Inc. is headquartered in United States

    When did Terns Pharmaceuticals, Inc. go public?

    Terns Pharmaceuticals, Inc.'s initial public offering (IPO) was on February 5, 2021

    Is Terns Pharmaceuticals, Inc. in the S&P 500?

    No, Terns Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Terns Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Terns Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Terns Pharmaceuticals, Inc. in the Dow Jones?

    No, Terns Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Terns Pharmaceuticals, Inc.'s last earnings report?

    Terns Pharmaceuticals, Inc.'s most recent earnings report was on November 12, 2025

    When does Terns Pharmaceuticals, Inc. report earnings?

    The date for Terns Pharmaceuticals, Inc.'s next earnings report has not been announced yet
    On this page